Literature DB >> 2338576

Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene C4.

K L Black1, W A King, K Ikezaki.   

Abstract

Intracarotid infusions of leukotriene C4 (LTC4) were used to selectively open the blood-tumor barrier in rats with RG-2 gliomas. Blood-brain and blood-tumor permeability was determined by quantitative autoradiography using 14C aminoisobutyric acid. Leukotriene C4 (4 micrograms total dose) infused into the carotid artery ipsilateral to the tumor increased twofold the unidirectional transfer constant for permeability within the tumor while no effect on permeability was seen in normal brain. No gamma glutamyl transpeptidase (gamma-GTP) activity was seen in tumor capillaries in contrast to high gamma-GTP in normal brain capillaries. These findings suggest that normal brain capillaries may resist the vasogenic effects of LTC4, while LTC4 will increase permeability in tumor capillaries. This could relate to the ability of gamma-GTP to act as an enzymatic barrier and inactivate leukotrienes in normal brain capillaries. Intracarotid LTC4 infusion may be a useful tool to selectively open the blood-tumor barrier for delivery of antineoplastic compounds.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2338576     DOI: 10.3171/jns.1990.72.6.0912

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  12 in total

1.  Effect of calcium antagonists on regional cerebral blood flow in transplanted rat brain tumors.

Authors:  K Matsukado; K Ikezaki; T Nomura; M Fukui
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

Review 2.  Blood-brain barrier and new approaches to brain drug delivery.

Authors:  W M Pardridge; R J Boado; K L Black; P A Cancilla
Journal:  West J Med       Date:  1992-03

Review 3.  Pharmacological blood-brain barrier modification for selective drug delivery.

Authors:  T F Cloughesy; K L Black
Journal:  J Neurooncol       Date:  1995-11       Impact factor: 4.130

4.  Nitric oxide synthase is expressed in experimental malignant glioma and influences tumour blood flow.

Authors:  I R Whittle; F Collins; P A Kelly; I Ritchie; J W Ironside
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

5.  RMP-7 : Potential as an Adjuvant to the Drug Treatment of Brain Tumours.

Authors:  A V Boddy; H D Thomas
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

6.  Differential expression of arachidonate 5-lipoxygenase transcripts in human brain tumors: evidence for the expression of a multitranscript family.

Authors:  R J Boado; W M Pardridge; H V Vinters; K L Black
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

7.  Neuropathological and neurophysiological effects of interstitial white matter autologous and non-autologous protein containing solutions: further evidence for a glioma derived permeability factor.

Authors:  I R Whittle; J W Ironside; I R Piper; J D Miller
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

8.  Reversible MR changes in the cat brain after cerebral fat embolism induced by triolein emulsion.

Authors:  Hak J Kim; Chang H Lee; Hae G Kim; Sang D Lee; Suk M Son; Yong W Kim; Choong K Eun; Seung M Kim
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

9.  Leukotriene E4 selectively increase the delivery of methotrexate to the C6 gliomas in rats.

Authors:  C C Chio; S J Lin; M T Lin
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

10.  Catalytic nucleic acid enzymes for the study and development of therapies in the central nervous system: Review Article.

Authors:  Richard Tritz; Cellia Habita; Joan M Robbins; German G Gomez; Carol A Kruse
Journal:  Gene Ther Mol Biol       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.